Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer
Joris van de Haar(The Netherlands Cancer Institute), Nicola Valeri(Royal Marsden NHS Foundation Trust)
Cited by 83
Related Papers
MIR21-induced loss of junctional adhesion molecule A promotes activation of oncogenic pathways, progression and metastasis in colorectal cancer
|Cell Death and Differentiation|2021|22